| 3D-QSAR | Three-dimensional quantitative SAR |
| aaRS | Aminoacyl-tRNA synthase |
| Abl | Abelson kinase |
| AD | Alzheimer’s disease |
| ALS | Amyotrophic lateral sclerosis |
| AUDA | 12-(1-Adamantan-1-ylureido)- dodecanoic acid |
| CAMK | Ca2+/calmodulin- dependent protein kinase |
| CB1/2 | Cannabinoid receptors 1/2 |
| CDK8/CycC | Cyclin-dependent kinase 8 and cyclin C |
| COMFA | Comparative molecular field analysis |
| CoMSIA | Comparative molecular similarity |
| COPD | Chronic obstructive pulmonary disease |
| COX-2 | Cyclooxygenase-type 2 |
| CXCL8 | Interleukin 8 |
| CXCR1/R2 | CXC Chemokine receptors 1/2 |
| DFG (DMG) | Asp-Phe-Gly motif |
| DMPK1 | Dystrophia myotonica protein kinase 1 |
| ERK | extracellular-regulated protein kinase |
| Flt3 | Fms related tyrosine kinase 3 |
| fMLP | N-formyl-methionyl-leucyl-phenylalanine |
| GIRK | G protein-gated inwardly-rectifying potassium channels |
| GSK3α | Glycogen synthase kinases type 3α |
| hCA II | Human carbonic anhydrase II |
| hCAIs | Human carbonic anhydrase inhibitors |
| Hck | Hemopoietic Cell Kinase |
| HD | Huntington’s disease |
| HeLa | Henrietta Lacks immortal cells |
| hERG | Human Ether-à-go-go-Related Gene |
| HFF | Human foreskin fibroblasts |
| HSB | Hybrid structure based (virtual screening approach) |
| HTS | High-throughput screening |
| HUVEC | Human umbilical vein endothelial cells |
| I-κB | Inhibitor of kappa B kinase |
| IKK (1/2) | IkB kinases type 1/2 |
| IL-1-/6/-17/-18 | Interleukin type 1/6/17/18 |
| JM | Juxta-membrane |
| JNK | c-Jun NH2-terminal kinase |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MBC | Minimum Bactericidal concentration |
| MES | Maximal electroshock seizure |
| MetRS | Methionyl-t-RNA synthetase |
| MFC | Minimum fungicidal concentration |
| MI | Myocardial infarction |
| MIC | Minimum inhibiting concentration |
| MLSCN | Molecular libraries screening center network |
| MLSMR | Molecular libraries small molecule repository |
| MS | Multiple sclerosis |
| MTIP | Myosin tail interacting protein |
| MyoA | Myosin A |
| NEK10 | NIMA (never in mitosis gene a)-related kinase 10 |
| NF-κΒ | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NGF | Nerve growth factor |
| ONIOM | N-Layered integrated molecular orbital & molecular mechanics |
| Panc-1 | Human pancreatic adenocarcinoma |
| PD | Parkinson’s disease |
| PDB | Protein data bank |
| PDGFR | Platelet derived growth factor |
| PfATP4 | Plasmodium falciparum p-type cation ATPase |
| PfProRS | Plasmodium falciparum prolyl-t-RNA-synthetase |
| PI3K | Protein inositol kinase 3 |
| PKC | Protein kinase C |
| PLK2, PLK3 | Polo-like kinase 2/3 |
| PPI | Protein-protein interaction |
| PTZ | Pentylenetetrazol-induced seizure |
| RAF/RAS | Rapidly accelerated Fibrosarcoma |
| RSV | Respiratory syncytial virus |
| SAR | Structure Activity Relationship |
| sEH | Soluble epoxide hydrolases |
| SUMO | Small ubiquitin-like modifier |
| Syk | Spleen tyrosine kinase |
| TNF-α | Tumor necrosis factor alpha |
| Trk | Tropomyosin receptor kinase |
| UBSAs | Ureido benzenesulfonamides |
| VEGF | Vascular endothelial growth factor |
| VEGFR1/2 | Vascular endothelial growth factor receptor |
| Zap-70 | Zeta Chain of T Cell Receptor Associated Protein Kinase 70 |